Volume 24 - Issue 2 - February 2016
Department
Research in Review
03/28/2016
Gary Goldenberg, MD, discusses the latest oral agents for individuals living with psoriasis.
Gary Goldenberg, MD, discusses the latest oral agents for individuals living with psoriasis.
Gary Goldenberg, MD, discusses...
03/28/2016
The Dermatologist
Research in Review
03/11/2016
Alina Goldenberg, MD, MAS, and Sharon E. Jacob, MD
Clinical manifestations of topical and systematic corticosteroid-induced contact dermatitis.
Clinical manifestations of topical and systematic corticosteroid-induced contact dermatitis.
Clinical manifestations of...
03/11/2016
The Dermatologist
Derm Dx
03/02/2016
A 68-year-old male presented for evaluation of an itchy rash on his back. The rash began 1 year ago and has spread to his buttocks and thighs. He has been using topical triamcinolone 0.1%, which has helped. He has no prior history of eczema....
A 68-year-old male presented for evaluation of an itchy rash on his back. The rash began 1 year ago and has spread to his buttocks and thighs. He has been using topical triamcinolone 0.1%, which has helped. He has no prior history of eczema....
A 68-year-old male presented for...
03/02/2016
The Dermatologist
03/23/2016
With the right teledermatology partner, your practice can quickly begin offering established patients and future patients the virtual care they seek in this digital age.
With the right teledermatology partner, your practice can quickly begin offering established patients and future patients the virtual care they seek in this digital age.
With the right teledermatology...
03/23/2016
The Dermatologist
03/11/2016
Many businesses and practices in the healthcare industry are lagging behind in their uptake of digital branding, and specifically, investing in a website that is not just reflective of their brand but functions well in today’s competitive...
Many businesses and practices in the healthcare industry are lagging behind in their uptake of digital branding, and specifically, investing in a website that is not just reflective of their brand but functions well in today’s competitive...
Many businesses and practices in...
03/11/2016
The Dermatologist
03/07/2016
Manage your online reputation with these 3 simple steps.
Manage your online reputation with these 3 simple steps.
Manage your online reputation...
03/07/2016
The Dermatologist
02/25/2016
FDA will hold a Psoriasis Patient-Focused Drug Development Public Meetingon Thursday, March 17, 2016, from 10:00 am to 4:00 pm in Silver Spring, MD.
The public meeting is intended to allow FDA to obtain patient perspectives on the impact of...
FDA will hold a Psoriasis Patient-Focused Drug Development Public Meetingon Thursday, March 17, 2016, from 10:00 am to 4:00 pm in Silver Spring, MD.
The public meeting is intended to allow FDA to obtain patient perspectives on the impact of...
FDA will hold a Psoriasis...
02/25/2016
The Dermatologist
News
News
03/07/2016
Studies using combination therapy for the treatment of onychomycosis demonstrated positive results, according to Anil Kumar Bhatta, MD, who presented this late-breaking research in procedural dermatology at the 2016 American Academy of...
Studies using combination therapy for the treatment of onychomycosis demonstrated positive results, according to Anil Kumar Bhatta, MD, who presented this late-breaking research in procedural dermatology at the 2016 American Academy of...
Studies using combination...
03/07/2016
The Dermatologist
News
03/02/2016
An oral Janus kinase inhibitor shows sustained efficacy over a 2 year period against chronic plaque psoriasis with 10 mg twice daily providing greater efficacy than 5 mg twice daily, according to a recent findings reported in an online paper...
An oral Janus kinase inhibitor shows sustained efficacy over a 2 year period against chronic plaque psoriasis with 10 mg twice daily providing greater efficacy than 5 mg twice daily, according to a recent findings reported in an online paper...
An oral Janus kinase inhibitor...
03/02/2016
The Dermatologist
Interactive Features
FDA Alerts
03/01/2016
Once-daily dapsone Gel, 7.5% (Aczone, Allergan PlC), a new prescription topical treatment for inflammatory and non-inflammatory acne in patients 12 years of age and older, received FDA approval.
Once-daily dapsone Gel, 7.5% (Aczone, Allergan PlC), a new prescription topical treatment for inflammatory and non-inflammatory acne in patients 12 years of age and older, received FDA approval.
Once-daily dapsone Gel, 7.5%...
03/01/2016
The Dermatologist
